The US has been experiencing a drug shortage recently, leading to negative consequences for patients and healthcare providers, compounded by soaring consumer costs. This presents an opportunity for Indian pharma companies to meet the demand for generic drugs in this US$ 527 billion market, and expand exports in the coming years....
India Business & Trade is a thought leadership initiative of the Trade Promotion Council of India, a premier trade promotion body recognised by the Department of Commerce, Government of India.
India Business & Trade
M-62, Saket, New Delhi-110064, India
Stay ahead in the dynamic world of trade and commerce with India Business & Trade’s weekly newsletter.
Copyright © 2026 India Business & Trade. All Rights Reserved
